Point72 (Difc) LTD Abbott Laboratories Call Options Transaction History

Point72 (Difc) LTD

  • $2.95 Trillion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$100.07 - $118.13 $1.34 Million - $1.58 Million
13,400 Added 51.15%
39,600 $4.51 Billion
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $4.86 Million - $5.42 Million
-48,200 Reduced 64.78%
26,200 $2.72 Billion
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $8.15 Million - $9 Million
74,400 New
74,400 $8.46 Billion

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email